This trial is enrolling 39 participants with chronic spinal cord injury and chronic central (neuropathic) pain to test the effect of repetitive transcranial magnetic stimulation (rTMS) on that pain. rTMS is a non-invasive technique which uses a magnetic field to stimulate the brain. An electric coil (held over the head) delivers magnetic pulses that activate parts of the brain underneath the coil. If included, participants will be randomly assigned to undergo 10 sessions over a 2-week period of either sham (inactive) or active rTMS, targeting either the primary motor cortex (a part of the brain which has been found previously to beneficially affect central pain) or the anterior cingulate cortex (another part which may also affect pain). Final testing for neuropathic pain will be performed after 12 weeks.
Type
Details
- Participants will be randomly assigned to undergo 10 sessions of sham transcranial magnetic stimulation (rTMS) or active rTMS at 5 Hz targeting either the primary motor cortex or the anterior cingulate cortex over a 2-week period. - rTMS is a non-invasive technique which uses a magnetic field to stimulate the brain. A coil (held over the head) delivers the magnetic pulses that activate parts of the brain directly under the coil. - Final testing for pain will be performed after 12 weeks.
Main benefits
Pain
Additional benefits
General health
Mental health and psychosocial factors
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more